The inactivation of JAK2/STAT3 signaling and desensitization of M1 mAChR in Minimal Hepatic Encephalopathy (MHE) and the protection of naringin against MHE

Cellular Physiology and Biochemistry

Volumn 34, Issue 6, 2014, Pages 1933-1950

  Ding, Saidan ^a   Hu, Jiangnan ^a   Yang, Jianjing ^a   Liu, Leping ^a   Huang, Weilong ^a   Gu, Xialong ^a   Ye, Yiru ^a   Huang, Lijie ^a   Liang, Yong ^a   Chen, Bicheng ^a   Zhuge, Qichuan ^a  

^a WENZHOU MEDICAL UNIVERSITY   (China)

Author keywords

Dopamine; JAK2 STAT3 axis; M1 type muscarinic acetylcholine receptor (M1 mAChR); Memory impairment; Minimal hepatic encephalopathy (MHE)

Indexed keywords

AURANTIIN; CHOLINE ACETYLTRANSFERASE; DOPAMINE; JANUS KINASE 2; MUSCARINIC M1 RECEPTOR; STAT3 PROTEIN; FLAVANONE DERIVATIVE; JAK2 PROTEIN, RAT; STAT3 PROTEIN, RAT;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BEHAVIOR ASSESSMENT; CHOLINERGIC NERVE CELL; COGNITION; COGNITIVE DEFECT; CONTROLLED STUDY; DESENSITIZATION; DOWN REGULATION; DRUG EFFECT; ENZYME ACTIVATION; ENZYME INACTIVATION; HEPATIC ENCEPHALOPATHY; LIVER PROTECTION; MEMORY DISORDER; NEUROMODULATION; NONHUMAN; PRIORITY JOURNAL; RAT; SIGNAL TRANSDUCTION; UPREGULATION; ANIMAL; BIOSYNTHESIS; DISEASE MODEL; DRUG EFFECTS; GENETICS; HUMAN; MEMORY DISORDERS; METABOLISM; NERVE CELL; PATHOLOGY;

RATTUS;

ANIMALS; DISEASE MODELS, ANIMAL; DOPAMINE; FLAVANONES; HEPATIC ENCEPHALOPATHY; HUMANS; JANUS KINASE 2; MEMORY DISORDERS; NEURONS; RATS; STAT3 TRANSCRIPTION FACTOR;

EID: 84917739726     PISSN: 10158987     EISSN: 14219778     Source Type: Journal    
DOI: 10.1159/000366391     Document Type: Article

References (46)

1. Aaronson DS, Horvath CM: A road map for those who dont know JAK-STAT. Science 2002;296:1653-1655
2. Levy DE, Darnell JE Jr: Stats: transcriptional control and biological impact. Nat Rev Mol Cell Biol 2002;3:651-662
3. Li WX: Canonical and non-canonical JAK-STAT signaling. Trends Cell Biol 2008;18:545-551
4. Chiba T, Yamada M, Sasabe J, Terashita K, Shimoda M, Matsuoka M, Aiso S: Amyloid-beta causes memory impairment by disturbing the JAK2/STAT3 axis in hippocampal neurons. Mol Psychiatry 2009;14:206-222
5. Chiba T, Yamada M, Aiso S: Targeting the JAK2/STAT3 axis in Alzheimer's disease. Expert Opin Ther Targets 2009;13:1155-1167
6. Park SJ, Shin EJ, Min SS, An J, Li Z, Hee Chung Y, Hoon Jeong J, Bach JH, Nah SY, Kim WK, Jang CG, Kim YS, Nabeshima YI, Nabeshima T, Kim HC: Inactivation of JAK2/STAT3 Signaling Axis and Downregulation of M1 mAChR Cause Cognitive Impairment in klotho Mutant Mice, a Genetic Model of Aging. Neuropsychopharmacol 2013;38:1426-1437
7. Anagnostaras SG, Murphy GG, Hamilton SE, Mitchell SL, Rahnama NP, Nathanson NM, Silva AJ: Selective cognitive dysfunction in acetylcholine M1 muscarinic receptor mutant mice. Nat Neurosci 2003;6:51-58
8. Caccamo A, Oddo S, Billings LM, Green KN, Martinez-Coria H, Fisher A, LaFerla FM: Ml receptors play a central role in modulating AD-like pathology in transgenic mice. Neuron 2006;49:671-682
9. Tan HH, Lee GH, Thia KT, Ng HS, Chow WC, Lui HF: Minimal hepatic encephalopathy runs a fluctuating course: results from a three-year prospective cohort follow-up study. Singap Med J 2009;50:255-260
10. Ding S, Liu L, Jing H, Xie J, Wang X, Mao J, Zhang X, Chen B, Zhuge QC: Dopamine from cirrhotic liver contributes to the impaired learning and memory ability of hippocampus in minimal hepatic encephalopathy. Hepa Int 2013;7:923-936. Doi 10.1007/sl2072-013-9431-6
11. Schroeter H, Boyd C, Spencer JP, Williams RJ, Cadenas E, Rice-Evans C: MAPK signaling in neurodegeneration: influences of flavonoids and of nitric oxide. Neurobiol Aging 2002;23:861-880
12. Golechha M, Chaudhry U, Bhatia J, Saluja D, Arya DS: Naringin protects against kainic acid-induced status epilepticus in rats: evidence for an antioxidant, anti-inflammatory and neuroprotective intervention. Biol Pharm Bull 2011;34:360-365
13. Kumar P, Kumar A: Protective effect of hesperidin and naringin against 3-nitropropionic acid induced Huntington's like symptoms in rats: possible role of nitric oxide. Behav Brain Res 2010;206:38-46
14. Wang DM, Yang YJ, Zhang L, Zhang X, Guan FF, Zhang LF: Naringin Enhances CaMKII Activity and Improves Long-Term Memory in a Mouse Model of Alzheimer's Disease. Int J Mol Sci 2013;14:5576-5586
15. Kumar A, Dogra S, Prakash A: Protective effect of naringin, a citrus flavonoid, against colchicine-induced cognitive dysfunction and oxidative damage in rats. J Med Food 2010;13:976-984
16. Kumar A, Prakash A, Dogra S: Naringin alleviates cognitive impairment, mitochondrial dysfunction and oxidative stress induced by D-galactose in mice. Food Chem Toxicol 2010;48:626-632
17. Prakash A, Shur B, Kumar A: Naringin protects memory impairment and mitochondrial oxidative damage against aluminium-induced neurotoxicity in rats. Int J Neurosci 2013;123:636-645
18. Maratha SR, Mahadevan N: Memory enhancing activity of naringin in unstressed and stressed mice: possible cholinergic and nitriergic modulation. Neurochem Res 2012;37:2206-2212
19. Jia L, Zhang MH: Comparison of probiotics and lactulose in the treatment of minimal hepatic encephalopathy in rats. World J Gastroentero 2005;11:908-911
20. Kawasumi M, Chiba T, Yamada M, Miyamae-Kaneko M, Matsuoka M, Nakahara J, Tomita T, Iwatsubo T, Kato S, Aiso S, Nishimoto I, Kouyama K: Targeted introduction of V642I mutation in amyloid precursor protein gene causes functional abnormality resembling early stage of Alzheimers disease in aged mice. Eur] Neurosci 2004;19:2826-2838
21. Yamada M, Chiba T, Sasabe J, Nawa M, Tajima H, Niikura T, Terashita K, Aiso S, Kita Y, Matsuoka M, Nishimoto I: Implanted cannula-mediated repetitive administration of Abeta25-35 into the mouse cerebral ventricle effectively impairs spatial working memory. Behav Brain Res 2005;164:139-146
22. Itoh J, Nabeshima T, Kameyama T: Utility of an elevated plus-maze for the evaluation of memory in mice: effects of nootropics, scopolamine and electroconvulsive shock. Psychopharmacology1990;101:27-33
23. Mamiya T, Noda Y, Nishi M, Takeshima H, Nabeshima T: Enhancement of spatial attention in nociceptin/ orphanin FQ receptor-knockout mice. Brain Res 1998;783:236-240
24. Marini AM, Paul SM: N-methyl-D-Aspartate receptor-mediated neuroprotection in cerebellar granule cells requires new RNA and protein synthesis. Proc Natl Acad Sci USA 1992;89:6555-6559
25. Wang D, Gao K, Li X, Shen X, Zhang X, Ma C, Qin C, Zhang L: Long-Term naringin consumption reverses a glucose uptake defect and improves cognitive deficits in a mouse model of Alzheimer's disease. Pharmacol Biochem Behav 2012;102:13-20
26. Berse B, Blusztajn JK: Coordinated up-regulation of choline acetyltransferase and vesicular acetylcholine transporter gene expression by the retinoic acid receptor alpha, cAMP, and leukemia inhibitory factor/ ciliary neurotrophic factor signaling pathways in a murine septal cell line. J Biol Chem 1995;270:22101-22104
27. Cheema SS, Arumugam D, Murray SS, Bartlett PF: Leukemia inhibitory factor maintains choline acetyltransferase expression in vivo. Neuroreport 1998;9:363-366
28. Bartus RT, Dean RL, 3rd., Beer B, Lippa AS: The cholinergic hypothesis of geriatric memory dysfunction. Science 1982;217:408-414
29. Coulthard EJ, Bogacz R, Javed S, Mooney LK, Murphy G, Keeley S, Whone AL: Distinct roles of dopamine and subthalamic nucleus in learning and probabilistic decision making. Brain 2012;135:3721-3734
30. Shiner T, Seymour B, Wunderlich K, Hill C, Bhatia KP, Dayan P, Dolan RJ: Dopamine and performance in a reinforcement learning task: evidence from Parkinsons disease. Brain 2012;135:1871-1883
31. Kobza S, Ferrea S, Schnitzler A, Pollok B, Sudmeyer M, Bellebaum C: Dissociation between active and observational learning from positive and negative feedback in Parkinsonism. Plos One 2012;7:e50250
32. Moustafa AA, Herzallah MM, Gluck MA: Dissociating the cognitive effects of levodopa versus dopamine agonists in a neurocomputational model of learning in Parkinsons disease. Neurodegener Dis 2013;11:102-111
33. Ding SD, Liu LP, Jing HJ, Xie JY, Wang XB, Mao JP, Chen BC, Zhuge QC: Dopamine from cirrhotic liver contributes to the impaired learning and memory ability of hippocampus in minimal hepatic encephalopathy. Hepa Inter 2013;7:923-936
34. Brodskii VY, Dubovaya TK, Zvezdina ND, Konchenko DS, Mal'chenko LA: Dopamine disorganizes the rhythm of protein synthesis disrupting self-organization of hepatocytes in vitro. B Exp Biol Med+ 2013;156:38-40
35. Brodskii VY, Mal'chenko LA, Dubovaya TK, Konchenko DS, Zvezdina ND: Administration of Dopamine to Rats Disorganizes the Rhythm of Protein Synthesis in Hepatocytes. B Exp Biol Med+ 2014;157:220-223
36. Butterworth RF: The liver-brain axis in liver failure: neuroinflammation and encephalopathy. Nat Rev Gastro Hepat 2013;10:522-528
37. Martins YC, Daniel-Ribeiro CT: A new hypothesis on the manifestation of cerebral malaria: the secret is in the liver. Med Hypotheses 2013;81:777-783
38. Skowronska M, Albrecht J: Alterations of blood brain barrier function in hyperammonemia: an overview. Neurotox Res 2012;21:236-244
39. Chastre A, Belanger M, Nguyen BN, Butterworth RF: Lipopolysaccharide precipitates hepatic encephalopathy and increases blood-brain barrier permeability in mice with acute liver failure. Liver Int DOI:10.1111/liv.l2252
40. Abdel Rahman TT, Abou Hashem RM, Abdel Guaad MA, Mortagy AK: Executive functions in chronic hepatitis C virus-infected elderly patients. Geriatr Gerontol Int DOI:10.1111/ggi.l2187
41. Mousseau DD, Perney P, Layrargues GP, Butterworth RF: Selective loss of pallidal dopamine D2 receptor density in hepatic encephalopathy. Neurosci Lett 1993;162:192-196
42. Bergeron M, Reader TA, Layrargues GP, Butterworth RF: Monoamines and metabolites in autopsied brain tissue from cirrhotic patients with hepatic encephalopathy. Neurochem Res 1989;14:853-859
43. Weissenborn K, Berding G, Kostler H: Altered striatal dopamine D2 receptor density and dopamine transport in a patient with hepatic encephalopathy. Metabolic Brain Dis 2000;15:173-178
44. Knell AJ, Davidson AR, Williams R, Kantamaneni BD, Curzon G: Dopamine and serotonin metabolism in hepatic encephalopathy. Brit Med J (BMJ) 1974;1:549-551
45. Borkowska HD, Oja SS, Oja OS, Saransaari P, Hilgier W, Albrecht J: N-methyl-D-Aspartate-evoked changes in the striatal extracellular levels of dopamine and its metabolites in vivo in rats with acute hepatic encephalopathy. Neurosci Lett 1999;268:151-154
46. Borkowska HD, Oja SS, Saransaari P, Albrecht J: Release of [3H]dopamine from striatal and cerebral cortical slices from rats with thioacetamide-induced hepatic encephalopathy: different responses to stimulation by potassium ions and agonists of ionotropic glutamate receptors. Neurochem Res 1997;22:101-106